NCT04660552View on ClinicalTrials.gov

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 30, 2023

Conditions
Autism Spectrum Disorder
Interventions
DEVICE

Cognilum TM: Light Treatment Condition

The children will wear the CognilumTM device for up to 15 minutes at a time, twice a week, for a period of 8 weeks.

Trial Locations (2)

10019

Dr. Steingold Psychology PC, New York

11229

Dr. Steingold Psychology PC, Brooklyn

All Listed Sponsors
lead

JelikaLite LLC

INDUSTRY

NCT04660552 - Transcranial Photobiomodulation for Reducing Autism Symptoms in Children | Biotech Hunter | Biotech Hunter